🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Thromboembolic and Bleeding Risk Stratification in Patients With Non-valvular Atrial Fibrillation

Recruitingn/aAges 18 Years - anyAllSaint Antoine University Hospital
NCT02741349 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The aim of the present prospective study is to further develop and validate a composite risk score predicting both ischemic and bleeding risk, based on epidemiologic, clinical, biological, and/or morphologic complementary data. First, the investigators will assess the predictive performance of current clinical risk scores. Second, the investigators will assess the potential predictive value of additional markers. Third, the investigators will aim to develop a new risk score.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults above 18 years of age * Presenting a NVAF which is paroxysmal, persistent or permanent and documented by an electrocardiogram (ECG) * Willing and able to give written informed consent Exclusion Criteria: * Patients presenting a clinically and echocardiographically significant valve disease defined as : * mitral stenosis with a valve area \< 2cm2 * mitral insufficiency (grade 3 or 4) * aortic insufficiency (grade 3 or 4) * tricuspid insufficiency (grade 3 or 4) * aortic stenosis with a valve area \< 1.5 cm2 * mechanical valve prosthèses * Secondary AF due to an acute cause (thyrotoxicosis, acute pericarditis, infection, systemic disease) * Presence of a contraindication to long term anticoagulant treatment * Absence of social security coverage * Severe psychiatric history * Impossibility of follow-up
💊

What it tests

  • Not listed
📍

Where

4 sites
Service de cardiologie - hôpital Saint Antoine
Paris, France
Service de cadiologie - Hôpital Pitié Salpêtrière
Paris, France
Centre Cardiologique du Nord
Saint-Denis, France
Service de cardiologie - Clinique Pasteur
Toulouse, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy